Susell Parra-Rojas

Dr. Susell Parra-Rojas

Department of Dentistry, Universidad Fernando Pessoa Canarias, Las Palmas, Canary Islands, Spain
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2024 in Current Oncology Reports
Verified
Journal Article
Closed access
PDF file
Susell Parra-RojasSusell Parra-Rojas
Susell Parra-Rojas
Rocío Trinidad Velázquez-CayónRocío Trinidad Velázquez-Cayón
Rocío Trinidad Velázquez-Cayón
ABAcorán Borges-Gil
Acorán Borges-Gil
JMJuan Luis Mejías-Torrus
Juan Luis Mejías-Torrus
JSJuliana Cassol Spanemberg
Juliana Cassol Spanemberg

22 January 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
Susell Parra-RojasSusell Parra-Rojas
Susell Parra-Rojas
Rocío Trinidad Velázquez-CayónRocío Trinidad Velázquez-Cayón
Rocío Trinidad Velázquez-Cayón
MCMaria Elena Ciortan-Pop
Maria Elena Ciortan-Pop
MMManoela Domingues Martins
Manoela Domingues Martins
JSJuliana Cassol Spanemberg
Juliana Cassol Spanemberg
Background/Objectives: Oral mucositis (OM) is the most common acute complication among cancer patients. It initially manifests as an inflammatory process, beginning with erythema and edema of the oral mucosa, progressing to erosive lesions, and ultimately leading to highly painful ulcers. This systematic review seeks to evaluate the efficacy of preventive PBM protocols in mitigating chemotherapy-induced OM. Methods: The PRISMA guidelines were followed. The search was conducted in August 2024 in the following databases: Pubmed/Medline, Scopus, WoS, Cochrane, SciELO, BDTD, and BVS/IBECS. Only randomized clinical trials that utilized preventive photobiomodulation protocols in chemotherapy patients were included. All studies involving patients previously treated with radiation therapy were excluded. The Joanna Briggs Institute tool was employed for risk of bias analysis. Results: The total sample size consisted of 828 patients aged between 1 and 84 years. There was no predisposition based on gender or age. When the patients were evaluated under preventive protocols, some cases of mucositis manifested in a total of 339 cases. Of the total number of patients in the 13 selected studies (n = 828), 40.94% developed oral mucositis over the course of chemotherapy cycles. Comparing the experimental and control groups, 211 patients who did not receive preventive laser treatment developed oral mucositis; in contrast, only 128 in the experimental group did. Eighty-five percent of the studies exhibited a low risk of bias. Conclusions: Preventively applied photobiomodulation proves effective in minimizing or even preventing the manifestation of oral mucositis and reducing the severity of lesions that arise during oncological treatment. Registration PROSPERO (CRD42023465329).

16 October 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
Susell Parra-RojasSusell Parra-Rojas
Susell Parra-Rojas
JSJuliana Cassol Spanemberg
Juliana Cassol Spanemberg
NRNerea del Mar Díaz Robayna
Nerea del Mar Díaz Robayna
MPMariela Peralta-Mamani
Mariela Peralta-Mamani
Rocío Trinidad Velázquez-CayónRocío Trinidad Velázquez-Cayón
Rocío Trinidad Velázquez-Cayón
Background: We report on the cost-effectiveness of photobiomodulation (PBM) for the prevention and treatment of oral mucositis (OM) derived from the cytotoxic effects of antineoplastic therapy. Methods: This review followed the PRISMA 2020 guidelines. A search was conducted in PubMed, Scopus, Web of Science, Embase, and OpenGrey. Articles published before 23 July 2024, were included. Randomized controlled trials (RCTs) that included patients with head and neck cancer undergoing chemotherapy and/or radiotherapy and a placebo group compared to an intervention group (PBM) were selected. The risk of bias was evaluated using the Joanna Briggs Institute tools. The certainty of the evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach and was rated as moderate. Results: A total of 3 RCTs and 229 patients were included. PBM may represent an additional cost in the short term, but the incremental expenses derived from the cytotoxic effects of antineoplastic therapy are greater in the medium–long term. The intervention group (PBM) showed a lower incidence of severe OM compared to the control group (placebo). Conclusions: PBM is a cost-effective long-term treatment, effective in preventing severe OM and improving the quality of life of cancer patients. More RCTs following the same standardized protocols are needed (registration CDR42024498825).

Rocío Trinidad Velázquez-CayónRocío Trinidad Velázquez-Cayón
Rocío Trinidad Velázquez-Cayón
ACAna Isabel Contreras-Madrid
Ana Isabel Contreras-Madrid
Susell Parra-RojasSusell Parra-Rojas
Susell Parra-Rojas
David Pérez-JorgeDavid Pérez-Jorge
David Pérez-Jorge
Numerous studies have shown the high incidence of diseases affecting oral health in vulnerable populations. The Canary Islands is a region particularly affected by the low income of its inhabitants and a high migration rate. Poor oral health habits and limited access to health care have turned these groups into risk groups. The role of the Fernando Pessoa Canarias University (CDUFPC) dental clinic in the health care of these groups has been an example of good professional practice and a fundamental resource in their health care. The present study aims to identify the profile of pathologies as well as the impact on the oral health of vulnerable population groups served by the CDUFPC. This study was developed between September 2019 and July 2022 with a sample of 878 patients, of whom 267 (30.4%) belonged to vulnerable groups referred by institutions and social organizations. The results identified the prevalence of dental caries as the main pathology and the lack of good oral habits and commitment to oral health and care.
1

23 March 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
Rocío Trinidad Velázquez-CayónRocío Trinidad Velázquez-Cayón
Rocío Trinidad Velázquez-Cayón
JSJuliana Cassol Spanemberg
Juliana Cassol Spanemberg
AAAna del Toro Arencibia
Ana del Toro Arencibia
ESElena Sirumal
Elena Sirumal
Susell Parra-RojasSusell Parra-Rojas
Susell Parra-Rojas
Background/Objectives: Oral diseases represent a major public health challenge in Africa, considering socioeconomic disparities and limited healthcare access. This systematic review aimed to comprehensively analyze the oral health status, conditions, and associated socioeconomic and cultural associated factors in North and West African regions. Methods: A systematic search was conducted in PubMed, Web of Science, and Scopus for cross-sectional studies. Using the CoCoPop framework, 19 studies were selected and evaluated for risk of bias using the JBI critical appraisal tool. Results: The findings reveal a substantial burden of untreated pathology, with localized caries prevalence reaching 74% in children. Periodontal health is consistently compromised in adults, characterized by high levels of calculus and gingival bleeding. Self-reported data highlight a symptom-driven culture, where lower-socioeconomic-status (SES) households rely on traditional remedies or emergency extractions due to economic and geographic barriers. Conclusions: Oral health in North and West Africa is characterized by profound inequalities. Current systems fail to reach vulnerable populations, emphasizing the urgent need for a structural shift toward integrated, equity-oriented primary care models that prioritize prevention over reactive, extraction-based treatments.

19 June 2026 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
Susell Parra-RojasSusell Parra-Rojas
Susell Parra-Rojas
JSJuliana Cassol Spanemberg
Juliana Cassol Spanemberg
APAlejandra Navarro Pérez
Alejandra Navarro Pérez
GBGabriela Leite Baggio
Gabriela Leite Baggio
Rocío Trinidad Velázquez-CayónRocío Trinidad Velázquez-Cayón
Rocío Trinidad Velázquez-Cayón